Quantitative Methods in Pharmaceutical Research and Development

Olga V. Marchenko is a Head of Clinical Statistics in Pulmonology, Anti-Infectives, Ophthalmology, and Women's Health at Bayer. Prior to joining Bayer, Dr. Marchenko was Vice President and Head of Advisory Analytics at QuintilesIMS. Dr. Marchenko received her Ph.D. in Statistics from the University of Michigan, Ann Arbor. She is an Associate Editor of the Journal of Biopharmaceutical Statistics and a Fellow of the American Statistical Association. Natallia V. Katenka is an Associate Professor in the Department of Computer Science and Statistics in the College of Arts and Sciences at the University of Rhode Island. A Ph.D. graduate from the University of Michigan, she is an expert in the statistical analysis of longitudinal, multivariate, and network data. Her research interests fall within the studies of HIV/AIDS networks, opioid use disorder, studies including educational networks, and networks in cybersecurity.

Biostatistics in Clinical Trials.- Pharmacometrics, A Quantitative Decision-Making Tool in Drug Development.- Genomics and Bioinformatics in Biological Discovery and Pharmaceutical Development.- Biostatistical Methods in Pharmacoepidemiology.- Causal Inference in Pharmacoepidemiology.- Statistical Data Mining of Clinical Data.- Segmentation and Choice Models.- Modern Analytic Techniques for Predictive Modeling of Clinical Trial Operations.- Better Together: Examples of Biostatisticians Collaborating in Drug Development.